Smith & Nephew has singed a distribution agreement with French biotechnology company Graftys, according to a company news release.
Under the agreement, Smith & Nephew will hold distribution rights for Graftys' fast-setting, macroporous calcium phosphate bone void filler in the United States with the potential for additional countries around the world.
Graftys produces an injectable, hard-setting resorbable calcium phosphate bone substitute which provides a support scaffold for bone growth. It can also be mixed and applied in situ.
Read the release about the partnership between Graftys and Smith & Nephew.
Related Articles on Smith & Nephew:
Smith & Nephew Introduces Short Modular Femoral Hip System
Smith & Nephew Introduce TWINFIX Suture Anchor for Rotator Cuff Repair
Smith & Nephew, Nanotope Partner in Cartilage Regeneration Project
Under the agreement, Smith & Nephew will hold distribution rights for Graftys' fast-setting, macroporous calcium phosphate bone void filler in the United States with the potential for additional countries around the world.
Graftys produces an injectable, hard-setting resorbable calcium phosphate bone substitute which provides a support scaffold for bone growth. It can also be mixed and applied in situ.
Read the release about the partnership between Graftys and Smith & Nephew.
Related Articles on Smith & Nephew:
Smith & Nephew Introduces Short Modular Femoral Hip System
Smith & Nephew Introduce TWINFIX Suture Anchor for Rotator Cuff Repair
Smith & Nephew, Nanotope Partner in Cartilage Regeneration Project